Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Today’s 8k is proof positive that Linda loves us and wants us to become filthy rich!
Except Shorty McFraudstain
Today’s 8k is a traders dream!
The coil is getting wound tight
Of course YOU would...
I expect a nice steady rise in price this week
FOMO
At this point any time is possible.
Gonna stick close to computer for next few weeks!!
After the market closes. So possible Pr Monday premarket
Don’t make Gary leak!
FOMO setting in eh??
Hopefully a neck ache
Did you say tilt????
Nope I stand corrected: in the last 10q there is this one liner:
As of June 30, 2020, approximately 166.5 million warrants were suspended until November 1, 2020.
During May 2020, the Company entered into financings totaling $3.3 million (the “May Financings”). The financings were comprised of $3.1 million from the offering of 15.7 million shares of common stock and 5.6 million warrants. The common stock was offered at a price between $0.17 and $0.225 per share. The warrants have an exercise price between $0.22 and $0.23 per share and an exercise period between 1.5-2.5 years.
All of the warrants issued in these financings are suspended until November 1, 2020. In addition, as part of these agreements, the investors who have existing outstanding warrants that have not already been suspended until November 1 are suspending approximately 14.6 million existing warrants until November 1, 2020.
Looks like 14.4 and 5.6 million warrants held by investors.
The Boogy Man is not that bad!
Happy Halloween!!
Looking at the filings it looks like about 20 million warrants from investors are exercisable tomorrow and 90 million warrants and stock options held by Linda Powers.
So many here are in denial of all the patients walking, talking, and living today
Then LSU happened!!!
Lol
The SEC is a joke
Progression free is old world chemo thinking
Must be close to results. Adam getting nervous
There is a game plan at work here. Can you put game the gamers???
Good luck all!!
Go easy Leonard. I’m just the messenger
Word around the campfire:
imminent
FYI:
NWBO Up 1021% YTD
Thank you for your time
Shorty McGhee just put his house for sale!
NWBO up 846% YTD
Good luck longs!
Steve G is screwed
I think the only limiting factor for the company will be how many batches they can produce.
Currently researching the Flaskworks technology
FYI:
NWBO up 631% YTD
Good luck all!!
FYI:
Up 558% TYD
Good Luck All!!!
Quote:
It is almost two years since I attended the Miami conference. I was not prepared to recommend it to you until now. I own it; Gramercy Capital and all of our clients own it. In recent weeks, NWBO has finally completed its Phase 3 trial. The data has been locked and sent off to the statisticians for evaluation.
Knowing that a lot of people who should be dead are not just alive but thriving, the trial was allowed to run for five years after the last patient was enrolled to gather complete data. Once the statisticians have analyzed the data, the study will be unblinded to the company and in turn to us.
Then a cascade of events will ensue: 1. The company will make a presentation at the Society of NeuroOncology on Nov. 20, at a main plenary session. 2. I anticipate that likely simultaneously an article will appear in a major medical journal of the importance of Cancer, Lancet, New England Journal or JAMA. 3. This stock will be relisted on a major stock exchange, perhaps even the NYSE making it easier for institutional investors to buy the stock. 4. This drug was “fast-tracked” in the UK in 2014 and I expect that a new drug application will be filed there very shortly after the results are known. 5. Applications will also be made in Germany, USA, and Canada. 6. UK approval could come in as few as three to five months after the filing pointing to approval as a 1H 2021 event.
Starting to get Wall Street coverage!!
FYI: NWBO up 334% YTD.
And results are pending!
This is much better than claytrader!
Thanks for clarifying.
Poor Scooter
This is beyond epic!
Pyrr is so screwed!!
Adam is screwed
The primary endpoint of this study is overall survival (OS) compared between patients randomized to DCVax-L and control patients from comparable, contemporaneous trials who received standard of care therapy only, in patients with newly diagnosed glioblastoma.
E.5.1.1 Timepoint(s) of evaluation of this end point
October 2020
E.5.2 Secondary end point(s)
The first secondary endpoint is overall survival (OS) compared between patients randomized to placebo who received DCVax-L treatment following disease recurrence, and control patients from comparable, contemporaneous clinical trials, in patients with recurrent GBM.
The second secondary endpoint, confirmed progression-free survival (cPFS), is confirmed disease progression (cPD) compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study 020221.
The third secondary endpoint, PFS, is progression-free survival compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study 020221.
The fourth secondary objective, OS, is overall survival compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study 020221.
The fifth secondary objective is tumor response compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study 020221.
This is incredible!!